Showing 1 - 10 of 9,817
pharmaceutical firms in Mexico. Results show that the influence of human resource management is contingent on the knowledge flows and …
Persistent link: https://www.econbiz.de/10008513249
pharmaceutical firms in Mexico. Results show that the influence of human resource management is contingent on the knowledge flows and …
Persistent link: https://www.econbiz.de/10010712046
developing countries. But why this is so? Based on evidence from the pharmaceutical industry in Mexico, this paper identifies …
Persistent link: https://www.econbiz.de/10008693155
developing countries. But why this is so? Based on evidence from the pharmaceutical industry in Mexico, this paper identifies …
Persistent link: https://www.econbiz.de/10010712332
This research investigates the hypothesis that publicly funded scientific research complements private R&D investment in the pharmaceutical industry. New microlevel data on public research investment by the U.S. National Institutes of Health allow measures of basic and clinical research in seven...
Persistent link: https://www.econbiz.de/10005097919
The TRIPS Agreement, which specifies minimum levels of intellectual property protection for countries in the WTO, has increased levels of patent protection around the world. Using variation across countries in the timing of patent laws and the severity of disease, we test the hypothesis that...
Persistent link: https://www.econbiz.de/10011010008
The life sciences sector (and biotechnology in particular) has emerged as a prospective area, and attracted a lot of attention recently. Multinational companies in the life sciences seek to explore new markets, and, on the other side, governments strive to develop the life sciences sector...
Persistent link: https://www.econbiz.de/10005150773
innovation networks and enterprise?s embeddedness. Above, especially in pharmaceuticals and biotechnology, these two …
Persistent link: https://www.econbiz.de/10008501948
The life sciences sector (and biotechnology in particular) has emerged as a prospective area, and attracted a lot of attention recently. Multinational companies in the life sciences seek to explore new markets, and, on the other side, governments strive to develop the life sciences sector...
Persistent link: https://www.econbiz.de/10010712051
recorded considerable changes. Notably, with the extension of patentability to pharmaceuticals, the sector is now at a dynamic …
Persistent link: https://www.econbiz.de/10005628145